Deep Lateral Wall Partial Rim-Sparing Orbital Decompression for Treatment of Thyroid-Related Orbitopathy

Sponsor
Hospital Universitario 12 de Octubre (Other)
Overall Status
Completed
CT.gov ID
NCT04025034
Collaborator
Hospital del Río Hortega (Other), The Queen Elizabeth Hospital (Other)
35
1
48

Study Details

Study Description

Brief Summary

The described technique of DLW-PRS decompression for TRO using SONOPET(R) appears to be safe and effective, reducing the complications associated with decompressing the orbital floor and medial wall. The mechanical characteristics of this surgical too provide protection to adjacent dura mater and neurovascular structures when working in narrow spaces.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Orbital decompression with ultrasonic bone removal
N/A

Detailed Description

We included in this review patients who had exophthalmos at presentation (using Hertel's exophthalmometer), underwent surgery for rehabilitation of disfiguring exophthalmos and had controlled thyroid function. All patients had a minimum follow up of 6 months. Procedures that potentially might have altered the amount of retroplacement achieved by lateral wall removal, such as fat excision, rim advancement, or decompression into the paranasal sinuses, were not performed. Patients with any history of previous procedures that potentially might have altered exophthalmos measurements were also excluded for the purposes of this study.

SONOPET® Ultrasonic Aspirator. The SONOPET® ultrasonic aspirator, consists of an ultrasonic handpiece that is connected to a base control module. The unit is foot-pedal controlled. The base module houses the controls to regulate the irrigation rate (between 3 and 40 mL/min), aspiration and ultrasound power parameters of the machine. The power setting is expressed as a percentage of that maximum. Aspiration reaches 500 mmHg and the aspiration setting on the machine is also expressed as a percentage of that maximum. The irrigation rate is expressed in milliliters per minute.18 Aspiration occurs through an opening at the distal aspect of the handpiece tip and the irrigation fluid (normal saline at 20°C) flows through a white irrigation sleeve surrounding the handpiece tip. The handpiece oscillates in a nonrotational fashion up to 25,000 times per second with a 0.36 mm width variation. The SONOPET®'s primary mechanism of action is torsional oscillation of a metal bone rasp at 25 kHz. This frequency is ideal for bone removal,22 as the microenvironment created only cuts mineralized tissue, while soft tissues are best cut at frequencies ≥34 kHz.23 The universal handpiece fits multiple interchangeable tips that have varying lengths, sizes, and shapes designed for specific soft tissue or bone removal purposes.22 Different sizes and angles for the cutting surface are also available.

The tip used in this series is a serrated aggressive knife and the superlong payner 360°shape designed for bone fragmentation and removal24 (Figures 1 D, 2 A).

Surgical technique. The procedure was performed with the patient in a supine position under general anesthesia. A single dose of IV dexamethasone (8 mg) and a 1 gr IV cefazoline were given during surgery. After corneal lubrication, the patient was prepped and draped in sterile fashion.

The marked triangle incision was incised (Figure 1, A) and an initial lateral canthotomy was made in a "crow's foot" using a no. 15 Bard-Parker® surgical blade (Becton Dickinson, Hancock, NY, USA) . Dissection was performed in the preseptal plane to provide wide exposure of the rim of the lateral orbital wall(Figure 1, B). The periosteum was incised using a needle-tip monopolar electrocautery and the lateral wall was completely exposed by cutting cautery and periosteal elevators (Figure 1, C). The posterior leaf of the periosteum was mobilized and reflected, along with the temporalis muscle; this minimizes damage to the temporalis muscle during surgery and reduces future temporal hollowing.

Study Design

Study Type:
Interventional
Actual Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Retrsopective, non-comparative case seriesRetrsopective, non-comparative case series
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Deep Lateral Wall Partial Rim-Sparing Orbital Decompression With Ultrasonic Bone Removal for Treatment of Thyroid-Related Orbitopathy
Actual Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Dec 1, 2017
Actual Study Completion Date :
Jan 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study Group

Use of SONOPET(R) to orbital surgery.

Procedure: Orbital decompression with ultrasonic bone removal
Deep lateral wall partial rim-sparing decompression for thyroid-related orbitopathy using SONOPET® appears to be safe and effective, reducing the complications associated and damage to neurovascular structures.

Outcome Measures

Primary Outcome Measures

  1. Orbital decompression in exophthalmos in treatment of thyroid-related orbitopahty [33 months]

    Decompression with a bone-cutting ultrasonic aspirator that can be customized for variable decompression of the orbit by tailoring the amount of bone removed from each wall.

  2. Change in proptosis [33 months]

    Measured by the difference in Hertel exophthalmometry

Secondary Outcome Measures

  1. Visual acuity [33 months]

    Using Snellen scale, decimal fraction

  2. Lagophthalmos [33 months]

    Presence of lagophthalmos

  3. Eyelid retraction [33 months]

    Measured by upper eyelid margin distance to the corneal reflex and lower eyelid margin distance to the corneal reflex

  4. Keratopathy [33 months]

    Presence of exposure keratopathy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Exopthalmos -

Exclusion Criteria: Previous procedures

-

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital Universitario 12 de Octubre
  • Hospital del Río Hortega
  • The Queen Elizabeth Hospital

Investigators

  • Study Director: Maria Ugalde-Diez, M.D., Ph.D., 12 de Octubre Hospital, Madrid

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Enrique Mencia-Gutierrez, M.D., Hospital Universitario 12 de Octubre
ClinicalTrials.gov Identifier:
NCT04025034
Other Study ID Numbers:
  • DLWP-R2019
First Posted:
Jul 18, 2019
Last Update Posted:
Jul 22, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Enrique Mencia-Gutierrez, M.D., Hospital Universitario 12 de Octubre
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2019